Pricing
Asceneuron
Contact
No bio yet
Barbara Angehrn Pavik
Chief Executive Officer
Bruno Permanne
Senior Director & Head of Preclinical Development
Colin Kahrs
Head of Intellectual Property
Ruhi Ahmed
SVP & Head of Regulatory Affairs
Sandra Millet
Head Of Operations
Eric Yuen
Scientific Advisory Board Member
Andrin Cerletti
Head Of Business Development
This person is not in any teams
This person is not in any offices
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease.
Industries
Headquarters
Employees
Links
Gdoc
Neu Ocean Technologies
Faraday Copper Corp.
Iron Software
Kaartje2go
View more